abstract |
(57) [Summary] General formula: Wherein R 1 and R 3 are independently hydrogen, —CH 3 , And R 2 is selected from the group consisting of pyrrolidino, hexamethyleneimino, and piperidino, and pharmaceutically acceptable salts or solvates thereof. A method for inhibiting plasminogen activator inhibitor 1, comprising administering to a human in need of inhibiting activator inhibitor 1. |